INR Blood Test: Monitoring Warfarin Therapy and Clotting Function
The INR (International Normalized Ratio) standardizes prothrombin time (PT) results across laboratories. It measures how long blood takes to clot.
Primary Uses
- Monitoring warfarin (Coumadin) anticoagulation therapy
- Assessing liver disease or clotting disorders
Interpretation
- Normal (off anticoagulants): 0.9–1.1
- Therapeutic range (most warfarin indications): 2.0–3.0
- High INR (>3–4): increased bleeding risk
- Low INR (<2): increased clotting risk
Factors Affecting INR
Many drugs interact with warfarin and alter INR: antibiotics (e.g., trimethoprim-sulfamethoxazole), NSAIDs, aspirin, amiodarone, antifungals, herbal supplements (ginkgo, garlic), and dietary vitamin K changes.
Monitoring Frequency
Initially frequent (2–3×/week), then every 1–4 weeks once stable. Point-of-care testing enables rapid dose adjustment.
Blood Disorders - Related Articles
- Boost Circulation Naturally: Foods for Improved Blood Flow
- Thrombosis: Blood Clot Formation, Risks, and Consequences
- Sickle Cell Anemia: Chromosome 11 & Genetic Cause
- Boost Circulation: Effective Ways to Improve Blood Flow in Limbs
- Understanding Bone Marrow Diseases: Causes, Symptoms & Treatments
- Heavy Menstrual Bleeding with Illness: Could It Be Miscarriage?
- Sickle Cell Anemia: Genetic Basis, Hemoglobin S, and Clinical Effects
